Onderzoeker
Thomas Van Stappen
- Disciplines:Laboratoriumgeneeskunde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen, Medische biotechnologie, Farmaceutica, Ontdekking en evaluatie van geneesmiddelen
Affiliaties
- Therapeutische en Diagnostische Antilichamen (Afdeling)
Lid
Vanaf1 apr 2013 → 14 nov 2017
Projecten
1 - 1 of 1
- Ontwikkeling en validatie van sneltesten om infliximab dalspiegels en antilichamen tegen infliximab kwantitatief te bepalen.Vanaf17 sep 2012 → 31 dec 2017Financiering: IWT persoonsgebonden financ. - strategische onderzoeksbeurzen
Publicaties
1 - 10 van 28
- Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial(2018)
Auteurs: Thomas Van Stappen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: 818 - 826 - Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial(2018)
Auteurs: Thomas Van Stappen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: 818 - 826 - Anti-infliximab antibody concentrations can guide on treatment intensification in patients with Crohn's disease who lose clinical response(2018)
Auteurs: Erwin Dreesen, Thomas Van Stappen, Vera Ballet, Kristel Van Steen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: 346 - 355 - Current practice for therapeutic drug monitoring of biopharmaceuticals in inflammatory bowel disease(2017)
Auteurs: Iris Detrez, Thomas Van Stappen, Ann Gils
Pagina's: 344 - 349 - Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay(2017)
Auteurs: Thomas Van Stappen, Séverine Vermeire, Ann Gils
Pagina's: 243 - 247 - Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®(2017)
Auteurs: Ann Gils, Thomas Van Stappen
Pagina's: 161 - 171 - Immunoassay for detection of infliximab in whole blood us-ing a fiber-optic SPR biosensor(2017)
Auteurs: Jiadi Lu, Dragana Spasic, Filip Delport, Thomas Van Stappen, Iris Detrez, Devin Daems, Séverine Vermeire, Ann Gils, Jeroen Lammertyn
Pagina's: 3664 - 3671 - Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation(2016)
Auteurs: Thomas Van Stappen, Lize Bollen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
- Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays(2016)
Auteurs: Sumin Bian, Thomas Van Stappen, Jeroen Lammertyn, Séverine Vermeire, Ann Gils
Pagina's: 62 - 67 - Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis(2016)
Auteurs: Iris Detrez, Erwin Dreesen, Thomas Van Stappen, Annick de Vries, Gert Van Assche, Séverine Vermeire, Marc Ferrante, Ann Gils
Pagina's: 575 - 581